Christophe Soulier
Director of Finance/CFO at Janssen Pharmaceuticals, Inc.
Christophe Soulier active positions
| Companies | Position | Start | End |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director of Finance/CFO | 2007-10-31 | - |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Private Equity Investor | 2023-02-07 | - |
Career history of Christophe Soulier
Former positions of Christophe Soulier
| Companies | Position | Start | End |
|---|---|---|---|
| JOHNSON & JOHNSON | Director of Finance/CFO | 2005-03-31 | 2007-09-30 |
| Private Equity Investor | 2002-07-31 | 2005-03-31 |
Training of Christophe Soulier
| University of Michigan | Masters Business Admin |
| Collège Stanislas de Paris | Undergraduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
| France | 2 |
Operational
| Director of Finance/CFO | 2 |
| Private Equity Investor | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Finance |
- Stock Market
- Insiders
- Christophe Soulier
- Experience
